Published in Vaccine Weekly, November 4th, 1996
The report was were presented at the 36th meeting of the American Society for Microbiology's Interscience Conference on Antimicrobial Agents and Chemotherapy, held September 15-18, 1996 in New Orleans, Louisiana.
It has long been recognized that targeted screening of children is less costly and more efficient in TB prevention as compared to mass screening.
"Unless local epidemiology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1996-11-04)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.